查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1619566

2024年酵素結合免疫吸附檢測法全球市場報告

Enzyme-Linked Immunosorbent Assay Testing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

酵素結合免疫吸附檢測法市場規模預計在未來幾年將強勁成長。 2028年，這一數字將以6.4%的複合年成長率成長至36.5億美元。預測期內的預期成長是由於多種因素造成的，包括對個性化醫療的需求不斷增加、人口老齡化加劇、對早期檢測的重視、獲得衛生服務的機會的改善以及對慢性病監測的需求不斷成長。在此期間預計的主要趨勢包括技術進步、對就地檢驗的需求不斷增加、應用領域的擴展、高效能篩檢的採用以及數位 ELISA 的出現。

傳染病發生率的增加預計將推動酵素結合免疫吸附檢測法（ELISA）測試市場的成長。由細菌、病毒、真菌、寄生蟲等病原微生物引起的感染疾病可以在個體之間傳播並影響身體的各個系統。這些疾病的增加是由於全球旅行增加和抗菌素抗藥性問題日益嚴重等因素造成的，這使得感染控制工作變得更加複雜。 ELISA 檢測可用於感染疾病的管理，因為它們可以準確檢測和量化與感染疾病相關的特定抗原和抗體，有助於診斷、監測疾病進展和評估治療效果。例如，2024年2月，總部位於瑞士的公共衛生機構世界衛生組織（WHO）報告稱，2023年歐洲記錄了58,114例麻疹病例，比2022年的941例大幅增加。感染疾病率的上升正在推動 ELISA 檢測市場的成長。

ELISA 測試市場的主要企業正在透過新型 ELISA套件等創新產品來改進其產品，以提高診斷準確性並滿足多樣化的研究和臨床需求。這些先進的 ELISA套件提高了生物標記檢測和定量的準確性、靈敏度和易用性。例如，2023 年 2 月，美國製藥公司 Charles River Laboratories 推出了一款新型 ELISA 試劑套件，旨在檢測和定量基於 CHO 的生物治療藥物中殘留的宿主細胞蛋白 (HCP)。本套件採用無特定病原體 (SPF) 蛋源性禽免疫球蛋白 Y (IgY) 抗體，檢測極限低至 0.1 ng/mL，抗體覆蓋率高達 90%，確保了高靈敏度和特異性。這項創新旨在加強生物製藥開發的品管，確保新治療方法的安全性和有效性。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球酵素結合免疫吸附檢測法市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球酵素結合免疫吸附檢測法市場表現：規模與成長，2018-2023
  • 全球酵素結合免疫吸附檢測法市場預測：規模與成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球酵素結合免疫吸附檢測法市場：按類型、性能和預測，2018-2023、2023-2028、2033
  • 直接酵素免疫分析法測定法 (ELISA)
  • 夾心酵素免疫分析法測定 (ELISA)
  • 間接酵素免疫分析法測定法 (ELISA)
  • 多功能可攜式酵素免疫分析法測定（ELISA）
  • 競爭性酵素免疫分析法測定法 (ELISA)
  • 全球酵素結合免疫吸附檢測法市場：按應用、性能和預測分類，2018-2023、2023-2028、2033
  • 免疫學
  • 發炎
  • 感染疾病
  • 癌症
  • 蛋白質定量
  • 其他
  • 全球酵素結合免疫吸附檢測法市場：按最終用戶、性能和預測，2018-2023、2023-2028、2033
  • 醫院和診斷中心
  • 實驗室
  • 其他

第 7 章 區域/國家分析

  • 全球酵素結合免疫吸附檢測法市場：按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球酵素結合免疫吸附檢測法市場：依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 酵素結合免疫吸附檢測法市場：競爭格局
  • 酵素結合免疫吸附檢測法市場：公司簡介
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Siemens Healthineers
    • Becton Dickinson and Company

第31章 其他大型創新企業

  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Tecan Group Ltd.
  • GenScript BIoTech Corporation
  • Promega Corporation
  • Abcam plc
  • R&D Systems Inc
  • Sino Biological Inc.
  • OriGene Technologies Inc.
  • RayBIoTech Inc.
  • Santa Cruz BIoTechnology Inc.
  • AnaSpec Inc.
  • Biomatik
  • Arigo Biolaboratories Corp.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來展望與潛力分析

第36章附錄

簡介目錄
Product Code: r20572

Enzyme-linked immunosorbent assay (ELISA) testing is a widely used laboratory technique designed to detect and quantify specific proteins, antigens, or antibodies in a sample. The method involves immobilizing an antigen or antibody on a solid surface, typically a microplate, and then using enzyme-linked antibodies or antigens to bind to the target molecule.

The main types of ELISA testing include direct enzyme-linked immunosorbent assay (ELISA), sandwich enzyme-linked immunosorbent assay (ELISA), indirect enzyme-linked immunosorbent assay (ELISA), multiple and portable enzyme-linked immunosorbent assays (ELISA), and competitive enzyme-linked immunosorbent assays (ELISA). Direct enzyme-linked immunosorbent assay (ELISA) involves directly immobilizing an antigen on a solid surface. This method can be used for applications in immunology, inflammation, infectious diseases, cancer, protein quantitation, and other areas, serving various end users such as hospitals and diagnostic centers, research laboratories, and more.

The enzyme-linked immunosorbent assay testing market research report is one of a series of new reports from The Business Research Company that provides enzyme-linked immunosorbent assay testing market statistics, including enzyme-linked immunosorbent assay testing industry global market size, regional shares, competitors with an enzyme-linked immunosorbent assay testing market share, detailed enzyme-linked immunosorbent assay testing market segments, market trends and opportunities, and any further data you may need to thrive in the enzyme-linked immunosorbent assay testing industry. This enzyme-linked immunosorbent assay testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The enzyme-linked immunosorbent assay testing market size has grown strongly in recent years. It will grow from $2.68 billion in 2023 to $2.85 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth observed during the historic period can be attributed to several factors, including the prevalence of chronic diseases, increased funding and focus on biomedical research, approval of ELISA tests by regulatory bodies, government initiatives, and health awareness programs.

The enzyme-linked immunosorbent assay testing market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The anticipated growth during the forecast period can be attributed to several factors, including rising demand for personalized medicine, an increasing geriatric population, a greater emphasis on early detection, improved access to healthcare services, and a growing need for chronic disease monitoring. Key trends expected during this period include technological advancements, a rising demand for point-of-care testing, expanding application areas, the adoption of high-throughput screening, and the emergence of digital ELISA.

The increasing incidence of infectious disorders is expected to drive growth in the enzyme-linked immunosorbent assay (ELISA) testing market. Infectious disorders, caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, can spread between individuals and affect various body systems. The rise in these disorders is due to factors such as increased global travel and the growing issue of antimicrobial resistance, which complicates infection control efforts. ELISA testing is valuable for managing infectious disorders as it enables precise detection and quantification of specific antigens or antibodies associated with infections, aiding in diagnosis, monitoring disease progression, and assessing treatment effectiveness. For example, in February 2024, the World Health Organization, a Switzerland-based public health organization, reported that 58,114 cases of measles were recorded in the European Region in 2023, a significant increase from 941 cases in 2022. This rising incidence of infectious disorders is thus propelling the growth of the ELISA testing market.

Leading companies in the ELISA testing market are advancing their product offerings with innovations such as novel ELISA kits to enhance diagnostic accuracy and address diverse research and clinical requirements. These advanced ELISA kits offer improved accuracy, sensitivity, and usability for detecting and quantifying biomarkers. For instance, in February 2023, Charles River Laboratories, a US-based pharmaceutical firm, launched a novel ELISA kit designed for detecting and quantifying residual host cell proteins (HCP) in CHO-based biotherapeutics. This kit employs avian immunoglobulin Y (IgY) antibodies derived from specific pathogen-free (SPF) chicken eggs, achieving enhanced sensitivity and specificity with detection limits as low as 0.1 ng/mL and 90% antibody coverage. This innovation aims to enhance quality control in biopharmaceutical development, ensuring the safety and efficacy of new therapies while offering flexibility for client use, either independently or with support from Charles River's experts.

In February 2024, Dyadic International Inc., a biotechnology company based in the US, formed a partnership with Cygnus Technologies to provide a C1 host cell protein (HCP) enzyme-linked immunosorbent assay designed to enhance quality assurance in biomanufacturing. This collaboration centers on quantifying host cell proteins derived from Dyadic's proprietary C1 cells, which utilize the filamentous fungus Thermothelomyces heterothallica. Cygnus Technologies LLC is also a biopharmaceutical company based in the US.

Major companies operating in the enzyme-linked immunosorbent assay testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Abcam plc, R&D Systems Inc, Sino Biological Inc., OriGene Technologies Inc., RayBiotech Inc., Santa Cruz Biotechnology Inc., AnaSpec Inc., Biomatik, Arigo Biolaboratories Corp., MyBioSource Inc., Boster Biological Technology, Eagle Biosciences Inc., Enzo Life Sciences Inc., StressMarq Biosciences Inc., XpressBio

North America was the largest region in the enzyme-linked immunosorbent assay testing market in 2023. The regions covered in the enzyme-linked immunosorbent assay testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the enzyme-linked immunosorbent assay testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The enzyme-linked immunosorbent assay testing market consists of revenues earned by entities providing services such as diagnostic testing, research and development, detection of antibodies, and vaccine development. The market value includes the value of related goods sold by the service provider or included within the service offering. The enzyme-linked immunosorbent assay testing market also includes sales of ELISA kits, control samples, inhibitor assays, and other consumables such as microplate readers, washers, and automated ELISA systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enzyme-Linked Immunosorbent Assay Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enzyme-linked immunosorbent assay testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enzyme-linked immunosorbent assay testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The enzyme-linked immunosorbent assay testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Direct Enzyme-Linked Immunosorbent Assay (ELISA); Sandwich Enzyme-Linked Immunosorbent Assay (ELISA); Indirect Enzyme-Linked Immunosorbent Assay (ELISA); Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA); Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
  • 2) By Application: Immunology; Inflammation; Infectious Diseases; Cancer; Protein Quantitation; Other Applications
  • 3) By End-User: Hospitals And Diagnostic Centers; Research Laboratories; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Siemens Healthineers; Becton Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Enzyme-Linked Immunosorbent Assay Testing Market Characteristics

3. Enzyme-Linked Immunosorbent Assay Testing Market Trends And Strategies

4. Enzyme-Linked Immunosorbent Assay Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Enzyme-Linked Immunosorbent Assay Testing Market Size and Growth

  • 5.1. Global Enzyme-Linked Immunosorbent Assay Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Enzyme-Linked Immunosorbent Assay Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Enzyme-Linked Immunosorbent Assay Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Enzyme-Linked Immunosorbent Assay Testing Market Segmentation

  • 6.1. Global Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Direct Enzyme-Linked Immunosorbent Assay (ELISA)
  • Sandwich Enzyme-Linked Immunosorbent Assay (ELISA)
  • Indirect Enzyme-Linked Immunosorbent Assay (ELISA)
  • Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA)
  • Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
  • 6.2. Global Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Immunology
  • Inflammation
  • Infectious Diseases
  • Cancer
  • Protein Quantitation
  • Other Applications
  • 6.3. Global Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Diagnostic Centers
  • Research Laboratories
  • Other End-Users

7. Enzyme-Linked Immunosorbent Assay Testing Market Regional And Country Analysis

  • 7.1. Global Enzyme-Linked Immunosorbent Assay Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Enzyme-Linked Immunosorbent Assay Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market

  • 8.1. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Enzyme-Linked Immunosorbent Assay Testing Market

  • 9.1. China Enzyme-Linked Immunosorbent Assay Testing Market Overview
  • 9.2. China Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Enzyme-Linked Immunosorbent Assay Testing Market

  • 10.1. India Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Enzyme-Linked Immunosorbent Assay Testing Market

  • 11.1. Japan Enzyme-Linked Immunosorbent Assay Testing Market Overview
  • 11.2. Japan Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Enzyme-Linked Immunosorbent Assay Testing Market

  • 12.1. Australia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Enzyme-Linked Immunosorbent Assay Testing Market

  • 13.1. Indonesia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Enzyme-Linked Immunosorbent Assay Testing Market

  • 14.1. South Korea Enzyme-Linked Immunosorbent Assay Testing Market Overview
  • 14.2. South Korea Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market

  • 15.1. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market Overview
  • 15.2. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Enzyme-Linked Immunosorbent Assay Testing Market

  • 16.1. UK Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Enzyme-Linked Immunosorbent Assay Testing Market

  • 17.1. Germany Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Enzyme-Linked Immunosorbent Assay Testing Market

  • 18.1. France Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Enzyme-Linked Immunosorbent Assay Testing Market

  • 19.1. Italy Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Enzyme-Linked Immunosorbent Assay Testing Market

  • 20.1. Spain Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market

  • 21.1. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market Overview
  • 21.2. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Enzyme-Linked Immunosorbent Assay Testing Market

  • 22.1. Russia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Enzyme-Linked Immunosorbent Assay Testing Market

  • 23.1. North America Enzyme-Linked Immunosorbent Assay Testing Market Overview
  • 23.2. North America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Enzyme-Linked Immunosorbent Assay Testing Market

  • 24.1. USA Enzyme-Linked Immunosorbent Assay Testing Market Overview
  • 24.2. USA Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Enzyme-Linked Immunosorbent Assay Testing Market

  • 25.1. Canada Enzyme-Linked Immunosorbent Assay Testing Market Overview
  • 25.2. Canada Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Enzyme-Linked Immunosorbent Assay Testing Market

  • 26.1. South America Enzyme-Linked Immunosorbent Assay Testing Market Overview
  • 26.2. South America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Enzyme-Linked Immunosorbent Assay Testing Market

  • 27.1. Brazil Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Enzyme-Linked Immunosorbent Assay Testing Market

  • 28.1. Middle East Enzyme-Linked Immunosorbent Assay Testing Market Overview
  • 28.2. Middle East Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Enzyme-Linked Immunosorbent Assay Testing Market

  • 29.1. Africa Enzyme-Linked Immunosorbent Assay Testing Market Overview
  • 29.2. Africa Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Enzyme-Linked Immunosorbent Assay Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Enzyme-Linked Immunosorbent Assay Testing Market Competitive Landscape And Company Profiles

  • 30.1. Enzyme-Linked Immunosorbent Assay Testing Market Competitive Landscape
  • 30.2. Enzyme-Linked Immunosorbent Assay Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Danaher Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Siemens Healthineers
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Becton Dickinson and Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Enzyme-Linked Immunosorbent Assay Testing Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. PerkinElmer Inc.
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. Tecan Group Ltd.
  • 31.5. GenScript Biotech Corporation
  • 31.6. Promega Corporation
  • 31.7. Abcam plc
  • 31.8. R&D Systems Inc
  • 31.9. Sino Biological Inc.
  • 31.10. OriGene Technologies Inc.
  • 31.11. RayBiotech Inc.
  • 31.12. Santa Cruz Biotechnology Inc.
  • 31.13. AnaSpec Inc.
  • 31.14. Biomatik
  • 31.15. Arigo Biolaboratories Corp.

32. Global Enzyme-Linked Immunosorbent Assay Testing Market Competitive Benchmarking

33. Global Enzyme-Linked Immunosorbent Assay Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Enzyme-Linked Immunosorbent Assay Testing Market

35. Enzyme-Linked Immunosorbent Assay Testing Market Future Outlook and Potential Analysis

  • 35.1 Enzyme-Linked Immunosorbent Assay Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Enzyme-Linked Immunosorbent Assay Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Enzyme-Linked Immunosorbent Assay Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer